Gabapentin: Difference between revisions
| [unchecked revision] | [unchecked revision] |
MDElliottMD (talk | contribs) Comprehensive categorization: +Calcium channel blockers (T-type or N/P/Q-type), Anticonvulsants / Antiepileptics |
MDElliottMD (talk | contribs) Recategorize: Stimulants & Wake-Promoting Agents -> Stimulants |
||
| Line 32: | Line 32: | ||
[[Category:Stimulants | [[Category:Stimulants]] | ||
[[Category:GABAergics]] | [[Category:GABAergics]] | ||
[[Category:Sedative-Hypnotics]] | [[Category:Sedative-Hypnotics]] | ||
[[Category:Calcium channel blockers (T-type or N/P/Q-type)]] | [[Category:Calcium channel blockers (T-type or N/P/Q-type)]] | ||
[[Category:Anticonvulsants / Antiepileptics]] | [[Category:Anticonvulsants / Antiepileptics]] | ||
Revision as of 10:44, 17 May 2026
Gabapentinoid, Anticonvulsant
Gabapentin
Neurontin
Experience
No personal reports yet
No clinical reports yet
Log in to add your own experience.
Problems
No problems yet. Be the first to suggest one.
+ Add a problemTitration strategies
No titration strategies yet. Be the first to suggest one.
Effects
No effects listed yet. Be the first to suggest one.
Interactions
No interactions reported yet.
Relevant anecdote
No anecdotes yet. Share a relevant one.
Relevant Literature
No literature entries yet.
Log in to submit relevant literature.
Summary
Classes
Gabapentinoid, Anticonvulsant
Pharmacy
Pharmacology
Purported mechanism
Alpha-2-delta voltage-gated calcium channel ligand